SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AVVAA WORLD HEALTH CARE PRODUCTS INC (CIK 0001092534) — Nov 22, 2005

AVVAA WORLD HEALTH CARE PRODUCTS INC (CIK 0001092534)
Date: Nov. 22, 2005 · CIK: 0001092534 · Accession: 0001013762-05-001660

AI Filing Summary & Sentiment

File numbers found in text: 333-124667

Date
November 15, 2005
Author
Not clearly detected
Form
CORRESP
Company
AVVAA WORLD HEALTH CARE PRODUCTS INC (CIK 0001092534)

Letter

November 15, 2005 VIA TELEFAX (202) 772-9217 Zafar Hasan, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549

Re: AVVAA World Health Care Products, Inc. Amendment No. 3 to Registration Statement on Form SB-2 File Number 333-124667

Dear Mr. Hasan:

We represent AVVAA World Health Care Products, Inc. ("AVVAA"). In response to Ms. Ibolya Ignat's verbal comments regarding the above referenced filing, the following are the Company's responses:

Question 1

In the SB-2 Amendment No.3 filing on page 21 in the MD&A you commented on the legal action with a former employee. Why did you not disclose this contingency in the related financial statements in accordance with FAS 5?

Answer: The Company has reviewed the August 31, 2005 financial statements and the contingency as disclosed in the note 14 and made the necessary adjustments to ensure compliance with FAS 5. The Company has added to Note 14, "The Company and its legal counsel believe that liability in excess of the recorded liability is remote."

Question 2 (a)

In the SB-2 Amendment No.3 on page 17 on the May 31, 2004 10 KSB financial statements, the related party was reclassified in the cash flow statement but was not reflected in the restatement footnote.

Answer: The cash flow statement has been adjusted in the May 31, 2004 financial statements summarizing changes and included a similar disclosure of the May 31, 2005 financial statements.

Related Parties had been reclassified to operating activities in the February 28, 2005 and the May 31, 2004 financial statements included in the SB-2 Amendment No.2 and no amendments were filed. But in the SB-2 Amendment No.3 both the amended May 31, 2004 and February 28, 2005 reflect advances from related parties as a financing activity not operating activity. <PAGE> Question 2 (b)

Please assure us that you have reviewed for consistency the SB-2 Amendment No.3 and all the restated financial statements.

Answer: The Company has compared the financial statements in the SB-2 Amendment No.3 with the amended financial statements in the various filings and found them consistent in every case with the exception of the cash flow statement in the Amendment No.1 to the May 31, 2005 10-KSB comparative figures in the Cash Flow Statement, and the necessary corrections have been made.

Question 3 (a)

In the May 31, 2005 10-KSB in paragraph 8 (a) regarding controls and procedures, you need to confirm whether or not your reevaluation indicated that the control procedures were effective at May 31, 2004.

Answer: The Company's revaluation determined that there was a deficiency in control procedures at May 31, 2004. The Company is satisfied that adequate control procedures are currently in place and no additional changes to the financial statements are required.

The last sentence of paragraph 8(a) of the May 31, 2005 10-KSB has been amended as follows:

"As a result of this re-evaluation, the Company believes that the errors relating to the deficient control procedures were detected and properly reflected in the financial statements. The company believes that its control procedures currently in place are effective."

Questions 3 (b)

As per Regulation 307, you need to ensure that your procedures not only include recording, processing, and summarization for reporting to management but also for reporting to shareholders and investors.

Answer: The first sentence of Item 8 (a) has been amended to document our current procedures, as follows:

"Our Chief Executive Officer and Chief Financial Officer (collectively the "Certifying Officers") maintain a system of disclosure controls and procedures that is designed to provide reasonable assurance that information which is required to be disclosed is recorded, processed, summarized and communicated to management and shareholders on a timely basis."

Question 4

Please change CFO certificate in the August 31 2005 10-QSB, as it incorrectly refers to "amendment number 1".

Answer: Please note that all certifications in the August 31, 2005 10-QSB have been amended to refer to Amendment No. 1, as the filing will be the first amendment.

<PAGE> If you have any questions, please call me.

Very truly yours,
ANSLOW & JACLIN, LLP

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
November 15, 2005

VIA TELEFAX (202) 772-9217
Zafar Hasan, Esq.
Securities and Exchange Commission
450 Fifth Street, NW
Washington, DC 20549

         Re:      AVVAA World Health Care Products, Inc.
                  Amendment No. 3 to Registration Statement on Form SB-2
                  File Number 333-124667

Dear Mr. Hasan:

We represent AVVAA World Health Care Products, Inc. ("AVVAA"). In response to
Ms. Ibolya Ignat's verbal comments regarding the above referenced filing, the
following are the Company's responses:

Question 1

In the SB-2 Amendment No.3 filing on page 21 in the MD&A you commented on the
legal action with a former employee. Why did you not disclose this contingency
in the related financial statements in accordance with FAS 5?

Answer: The Company has reviewed the August 31, 2005 financial statements and
the contingency as disclosed in the note 14 and made the necessary adjustments
to ensure compliance with FAS 5. The Company has added to Note 14, "The Company
and its legal counsel believe that liability in excess of the recorded liability
is remote."

Question 2 (a)

 In the SB-2 Amendment No.3 on page 17 on the May 31, 2004 10 KSB financial
statements, the related party was reclassified in the cash flow statement but
was not reflected in the restatement footnote.

Answer: The cash flow statement has been adjusted in the May 31, 2004 financial
statements summarizing changes and included a similar disclosure of the May 31,
2005 financial statements.

Related Parties had been reclassified to operating activities in the February
28, 2005 and the May 31, 2004 financial statements included in the SB-2
Amendment No.2 and no amendments were filed. But in the SB-2 Amendment No.3 both
the amended May 31, 2004 and February 28, 2005 reflect advances from related
parties as a financing activity not operating activity.
<PAGE>
Question 2 (b)

Please assure us that you have reviewed for consistency the SB-2 Amendment No.3
and all the restated financial statements.

Answer: The Company has compared the financial statements in the SB-2 Amendment
No.3 with the amended financial statements in the various filings and found them
consistent in every case with the exception of the cash flow statement in the
Amendment No.1 to the May 31, 2005 10-KSB comparative figures in the Cash Flow
Statement, and the necessary corrections have been made.

Question 3 (a)

In the May 31, 2005 10-KSB in paragraph 8 (a) regarding controls and procedures,
you need to confirm whether or not your reevaluation indicated that the control
procedures were effective at May 31, 2004.

Answer: The Company's revaluation determined that there was a deficiency in
control procedures at May 31, 2004. The Company is satisfied that adequate
control procedures are currently in place and no additional changes to the
financial statements are required.

The last sentence of paragraph 8(a) of the May 31, 2005 10-KSB has been amended
as follows:

 "As a result of this re-evaluation, the Company believes that the errors
relating to the deficient control procedures were detected and properly
reflected in the financial statements. The company believes that its control
procedures currently in place are effective."

Questions 3 (b)

As per Regulation 307, you need to ensure that your procedures not only include
recording, processing, and summarization for reporting to management but also
for reporting to shareholders and investors.

Answer: The first sentence of Item 8 (a) has been amended to document our
current procedures, as follows:

"Our Chief Executive Officer and Chief Financial Officer (collectively the
"Certifying Officers") maintain a system of disclosure controls and procedures
that is designed to provide reasonable assurance that information which is
required to be disclosed is recorded, processed, summarized and communicated to
management and shareholders on a timely basis."

Question 4

Please change CFO certificate in the August 31 2005 10-QSB, as it incorrectly
refers to "amendment number 1".

Answer: Please note that all certifications in the August 31, 2005 10-QSB have
been amended to refer to Amendment No. 1, as the filing will be the first
amendment.

<PAGE>
If you have any questions, please call me.

Very truly yours,

ANSLOW & JACLIN, LLP

BY:   /s/ Richard I. Anslow
      ---------------------
      RICHARD I. ANSLOW

</TEXT>
</DOCUMENT>